These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19912203)
1. Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy. Schroeck FR; Kattan MW; Moul JW; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Sun L; Freedland SJ BJU Int; 2010 Jun; 105(12):1654-9. PubMed ID: 19912203 [TBL] [Abstract][Full Text] [Related]
2. Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. Teeter AE; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ Urology; 2013 Jul; 82(1):53-8. PubMed ID: 23806388 [TBL] [Abstract][Full Text] [Related]
3. Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases. Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Sun LL; Moul JW; Freedland SJ Int J Urol; 2010 Nov; 17(11):914-22. PubMed ID: 20880361 [TBL] [Abstract][Full Text] [Related]
4. External validation of the SEARCH model for predicting aggressive recurrence after radical prostatectomy: results from the Duke Prostate Center Database. Teeter AE; Sun L; Moul JW; Freedland SJ BJU Int; 2010 Sep; 106(6):796-800. PubMed ID: 20151967 [TBL] [Abstract][Full Text] [Related]
5. Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? Schroeck FR; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ BJU Int; 2009 Mar; 103(5):603-8. PubMed ID: 19021608 [TBL] [Abstract][Full Text] [Related]
6. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759 [TBL] [Abstract][Full Text] [Related]
7. The Shared Equal Access Regional Cancer Hospital (SEARCH) nomogram for risk stratification in intermediate risk group of men with prostate cancer: validation in the Duke Prostate Center database. Jayachandran J; Schroeck F; Sun L; Gerber L; Moreira DM; Moul JW; Freedland SJ BJU Int; 2010 Jan; 105(2):180-4. PubMed ID: 19709074 [TBL] [Abstract][Full Text] [Related]
8. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. Briganti A; Karnes RJ; Joniau S; Boorjian SA; Cozzarini C; Gandaglia G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Sun M; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T Eur Urol; 2014 Sep; 66(3):479-86. PubMed ID: 24345725 [TBL] [Abstract][Full Text] [Related]
9. The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Sun LL; Moul JW; Freedland SJ Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):87-93. PubMed ID: 19918263 [TBL] [Abstract][Full Text] [Related]
10. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database. Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946 [TBL] [Abstract][Full Text] [Related]
11. Does early prostate-specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group. Teeter AE; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ BJU Int; 2009 Dec; 104(11):1604-9. PubMed ID: 19549124 [TBL] [Abstract][Full Text] [Related]
12. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy. Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827 [TBL] [Abstract][Full Text] [Related]
13. A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Suardi N; Porter CR; Reuther AM; Walz J; Kodama K; Gibbons RP; Correa R; Montorsi F; Graefen M; Huland H; Klein EA; Karakiewicz PI Cancer; 2008 Mar; 112(6):1254-63. PubMed ID: 18286530 [TBL] [Abstract][Full Text] [Related]
14. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy. Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280 [TBL] [Abstract][Full Text] [Related]
15. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity. Campbell JM; Raymond E; O'Callaghan ME; Vincent AD; Beckmann KR; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti KL Clin Genitourin Cancer; 2017 Oct; 15(5):e827-e834. PubMed ID: 28666689 [TBL] [Abstract][Full Text] [Related]
16. Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer. Kang M; Jeong CW; Choi WS; Park YH; Cho SY; Lee S; Lee SB; Ku JH; Hong SK; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE; PLoS One; 2014; 9(6):e100053. PubMed ID: 24936784 [TBL] [Abstract][Full Text] [Related]
17. External validation of two web-based postoperative nomograms predicting the probability of early biochemical recurrence after radical prostatectomy: a retrospective cohort study. Yoneda K; Utsumi T; Somoto T; Wakai K; Oka R; Endo T; Yano M; Kamiya N; Hiruta N; Suzuki H Jpn J Clin Oncol; 2018 Feb; 48(2):195-199. PubMed ID: 29228232 [TBL] [Abstract][Full Text] [Related]
18. Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation. Hansen J; Becker A; Kluth LA; Rink M; Steuber T; Zacharias M; Briganti A; Fisch M; Graefen M; Chun FK Urol Oncol; 2015 Sep; 33(9):384.e1-8. PubMed ID: 26122714 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer. Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129 [TBL] [Abstract][Full Text] [Related]
20. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy? Boorjian SA; Bianco FJ; Scardino PT; Eastham JA BJU Int; 2005 Oct; 96(6):773-6. PubMed ID: 16153197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]